IMAC HOLDINGS INC (IMAC) Fundamental Analysis & Valuation

NASDAQ:IMAC • US44967K1043

Current stock price

1.01 USD
+0.02 (+2%)
Last:

This IMAC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IMAC Profitability Analysis

1.1 Basic Checks

  • In the past year IMAC has reported negative net income.
IMAC Yearly Net Income VS EBIT VS OCF VS FCFIMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -48.41%
ROE N/A
ROIC -45.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMAC Yearly ROA, ROE, ROICIMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 50 -50 100

1.3 Margins

Industry RankSector Rank
OM -72.27%
PM (TTM) -76.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMAC Yearly Profit, Operating, Gross MarginsIMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. IMAC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IMAC is destroying value.
  • The number of shares outstanding for IMAC has been increased compared to 1 year ago.
  • Compared to 1 year ago, IMAC has an improved debt to assets ratio.
IMAC Yearly Shares OutstandingIMAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
IMAC Yearly Total Debt VS Total AssetsIMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

2.2 Solvency

  • IMAC has an Altman-Z score of -0.90. This is a bad value and indicates that IMAC is not financially healthy and even has some risk of bankruptcy.
  • IMAC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACC-5.63
WACC8.14%
IMAC Yearly LT Debt VS Equity VS FCFIMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 5M -5M 10M 15M

2.3 Liquidity

  • IMAC has a Current Ratio of 1.27. This is a normal value and indicates that IMAC is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.27 indicates that IMAC should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
IMAC Yearly Current Assets VS Current LiabilitesIMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. IMAC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 13.64% over the past year.
  • Looking at the last year, IMAC shows a very strong growth in Revenue. The Revenue has grown by 21.05%.
  • IMAC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 272.72% yearly.
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)21.05%
Revenue growth 3Y29.01%
Revenue growth 5Y272.72%
Sales Q2Q%27.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.32% on average over the next years.
  • The Revenue is expected to grow by 22.61% on average over the next years. This is a very strong growth
EPS Next Y2.98%
EPS Next 2Y7.43%
EPS Next 3Y4.29%
EPS Next 5Y2.32%
Revenue Next Year21.45%
Revenue Next 2Y23.21%
Revenue Next 3Y22.4%
Revenue Next 5Y22.61%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IMAC Yearly Revenue VS EstimatesIMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IMAC Yearly EPS VS EstimatesIMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. IMAC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IMAC. In the last year negative earnings were reported.
  • Also next year IMAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMAC Price Earnings VS Forward Price EarningsIMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.44
IMAC Per share dataIMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.43%
EPS Next 3Y4.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMAC Dividend Analysis

5.1 Amount

  • IMAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

IMAC Fundamentals: All Metrics, Ratios and Statistics

IMAC HOLDINGS INC

NASDAQ:IMAC (8/5/2022, 8:25:24 PM)

1.01

+0.02 (+2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-12
Earnings (Next)08-23
Inst Owners11.86%
Inst Owner Change-2.36%
Ins Owners8.88%
Ins Owner Change0%
Market Cap26.75M
Revenue(TTM)15.22M
Net Income(TTM)-11.71M
Analysts80
Price Target3.59 (255.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.76
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB N/A
EV/EBITDA -2.44
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.57
BVpS0.57
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.41%
ROE N/A
ROCE N/A
ROIC -45.82%
ROICexc N/A
ROICexgc -99.32%
OM -72.27%
PM (TTM) -76.98%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -0.9
F-Score4
WACC8.14%
ROIC/WACC-5.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y2.98%
EPS Next 2Y7.43%
EPS Next 3Y4.29%
EPS Next 5Y2.32%
Revenue 1Y (TTM)21.05%
Revenue growth 3Y29.01%
Revenue growth 5Y272.72%
Sales Q2Q%27.29%
Revenue Next Year21.45%
Revenue Next 2Y23.21%
Revenue Next 3Y22.4%
Revenue Next 5Y22.61%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

IMAC HOLDINGS INC / IMAC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IMAC HOLDINGS INC (IMAC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMAC.


What is the valuation status for IMAC stock?

ChartMill assigns a valuation rating of 2 / 10 to IMAC HOLDINGS INC (IMAC). This can be considered as Overvalued.


How profitable is IMAC HOLDINGS INC (IMAC) stock?

IMAC HOLDINGS INC (IMAC) has a profitability rating of 1 / 10.


Can you provide the financial health for IMAC stock?

The financial health rating of IMAC HOLDINGS INC (IMAC) is 3 / 10.


What is the expected EPS growth for IMAC HOLDINGS INC (IMAC) stock?

The Earnings per Share (EPS) of IMAC HOLDINGS INC (IMAC) is expected to grow by 2.98% in the next year.